Key Statistics
Market Cap$440.26M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$3.76
52W High$16.19
52W Low$5.04
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees371
Price Performance
1 Week+9.92%
3 Month-36.34%
1 Year+27.89%
FinancialsAnnual · QuiverQuant
Revenue$90.24M
Assets$573.97M
Liabilities$262.23M
Net Income$263.49M loss
About
REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies intended to affect disease. The company is headquartered in Rockville, Maryland.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze RGNX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.